LCLAT1 antibody (AA 261-360)
Quick Overview for LCLAT1 antibody (AA 261-360) (ABIN5675401)
Target
See all LCLAT1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 261-360
-
Purpose
- LCLAT1 Polyclonal Antibody
-
Cross-Reactivity
- Mouse, Rat
-
Predicted Reactivity
- Human,Dog,Cow,Sheep,Horse,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human LCLAT1
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB(1:300-5000),
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- LCLAT1 (Lysocardiolipin Acyltransferase 1 (LCLAT1))
-
Alternative Name
- LCLAT1
-
Background
-
Synonyms: Lysocardiolipin acyltransferase 1, LCLAT1, 1-acylglycerol-3-phosphate O-acyltransferase 8, 1-AGP acyltransferase 8, 1-AGPAT 8, Acyl-CoA:lysocardiolipin acyltransferase 1, LCLAT1, AGPAT8, ALCAT1, LYCAT, UNQ1849/PRO3579
Background: Acyl-CoA:lysocardiolipin acyltransferase. Possesses both lysophosphatidylinositol acyltransferase (LPIAT) and lysophosphatidylglycerol acyltransferase (LPGAT) activities. Recognizes both monolysocardiolipin and dilysocardiolipin as substrates with a preference for linoleoyl-CoA and oleoyl-CoA as acyl donors. Acts as a remodeling enzyme for cardiolipin, a major membrane polyglycerophospholipid. Converts lysophosphatidic acid (LPA) into phosphatidic acid (PA) with a relatively low activity. Required for establishment of the hematopoietic and endothelial lineages.
-
Gene ID
- 253558
-
UniProt
- Q6UWP7
Target
-